Peer Review reports
From: Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
| Original Submission | ||
|---|---|---|
| 23 Jul 2018 | Submitted | Original manuscript |
| 19 Aug 2018 | Reviewed | Reviewer Report - Subramanyeswara Rao Arekapudi |
| 30 Aug 2018 | Reviewed | Reviewer Report - Mohammad Aziz |
| 17 Sep 2018 | Author responded | Author comments - Sabrina Heynckes |
| Resubmission - Version 2 | ||
| 17 Sep 2018 | Submitted | Manuscript version 2 |
| 24 Oct 2018 | Reviewed | Reviewer Report - Wang Jia |
| 3 Dec 2018 | Reviewed | Reviewer Report - Mohammad Aziz |
| 15 Dec 2018 | Author responded | Author comments - Sabrina Heynckes |
| Resubmission - Version 3 | ||
| 15 Dec 2018 | Submitted | Manuscript version 3 |
| 11 Jan 2019 | Author responded | Author comments - Sabrina Heynckes |
| Resubmission - Version 4 | ||
| 11 Jan 2019 | Submitted | Manuscript version 4 |
| Publishing | ||
| 17 Jan 2019 | Editorially accepted | |
| 1 Feb 2019 | Article published | 10.1186/s12885-019-5308-y |
You can find further information about peer review here.